UniSuper Management’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$12.2M Buy
55,423
+24,498
+79% +$6.78M 0.06% 175
2026
Q1
$9.13M Buy
30,925
+2,047
+7% +$608K 0.06% 174
2025
Q4
$7.89M Sell
28,878
-251
-0.9% -$68.2K 0.05% 185
2025
Q3
$7.87M Buy
29,129
+4,830
+20% +$1.31M 0.05% 196
2025
Q2
$6.7M Sell
24,299
-800
-3% -$218K 0.04% 199
2025
Q1
$6.66M Buy
25,099
+438
+2% +$108K 0.05% 184
2024
Q4
$5.73M Buy
24,661
+3,323
+16% +$764K 0.04% 204
2024
Q3
$4.71M Buy
21,338
+2,167
+11% +$448K 0.04% 241
2024
Q2
$3.77M Buy
19,171
+9,931
+107% +$2.05M 0.03% 243
2024
Q1
$1.99M Buy
9,240
+6,326
+217% +$1.33M 0.02% 255
2023
Q4
$614K Buy
2,914
+314
+12% +$67K 0.01% 308
2023
Q3
$521K Hold
2,600
0.01% 317
2023
Q2
$482K Buy
+2,600
New +$480K 0.01% 323

Other funds holding CME

UniSuper Management's CME Position: Q2 2026 in Review

UniSuper Management increased its CME Group (CME) stake by 79% in Q2 2026, buying an estimated $6.78M and bringing the position to 55,423 shares worth $12.2M. The position accounts for 0.06% of the portfolio, ranked #175.

UniSuper Management first reported a position in CME in Q2 2023 and has held it in 13 quarters since. 1,701 funds tracked by Wall St. Rank hold CME as of Q2 2026.

  • UniSuper Management held 55,423 shares of CME Group worth $12.2M as of Q2 2026.
  • UniSuper Management bought 24,498 CME Group shares in Q2 2026, an estimated $6.78M.
  • CME Group made up 0.06% of UniSuper Management's portfolio in Q2 2026, its #175 holding.
  • UniSuper Management first reported a position in CME Group in Q2 2023 and has held it in 13 quarters since.
  • 1,701 funds tracked by Wall St. Rank held CME Group as of Q2 2026.

Based on UniSuper Management's 13F filing for Q2 2026, filed 14 Aug 2026.